Literature DB >> 35429747

The impact of zinc on the molecular signaling pathways in the diabetes disease.

Keyvan Asghari1, Zahra Shargh1, Sina Fatehfar1, Leila Chodari2, Parsa Sameei3.   

Abstract

Since there's been an upsurge in people with diabetes or pre-diabetes conditions, many studies have been conducted to evaluate approaches for reducing the complications of diabetes. One of the most common therapeutic elements suggested for this purpose is zinc (Zn). Zn has long been shown to positively improve complications of both type 1 and type 2 diabetes. This review aims to provide comprehensive information about the influence of Zn on the various signaling pathways in multiple tissues with diabetic conditions, with great attention to the treatment period and effective dose of Zn.
Copyright © 2022. Published by Elsevier GmbH.

Entities:  

Keywords:  Diabetes; Molecular signaling pathways; Zinc

Year:  2022        PMID: 35429747     DOI: 10.1016/j.jtemb.2022.126985

Source DB:  PubMed          Journal:  J Trace Elem Med Biol        ISSN: 0946-672X            Impact factor:   3.849


  3 in total

Review 1.  Interplay between Zn2+ Homeostasis and Mitochondrial Functions in Cardiovascular Diseases and Heart Ageing.

Authors:  Siarhei A Dabravolski; Nikolay K Sadykhov; Andrey G Kartuesov; Evgeny E Borisov; Vasily N Sukhorukov; Alexander N Orekhov
Journal:  Int J Mol Sci       Date:  2022-06-21       Impact factor: 6.208

Review 2.  The Role of Mitochondrial Abnormalities in Diabetic Cardiomyopathy.

Authors:  Siarhei A Dabravolski; Nikolay K Sadykhov; Andrey G Kartuesov; Evgeny E Borisov; Vasily N Sukhorukov; Alexander N Orekhov
Journal:  Int J Mol Sci       Date:  2022-07-16       Impact factor: 6.208

3.  Biosynthesis of ZnONP Using Chamaecostus cuspidatus and Their Evolution of Anticancer Property in MCF-7 and A549 Cell Lines.

Authors:  Menaka Priya Balaji; Rajakumar Govindasamy; Naiyf S Alharbi; Shine Kadaikunnan; Muthu Thiruvengadam; Venkidasamy Baskar; Vijayarangan Devi Rajeswari
Journal:  Nanomaterials (Basel)       Date:  2022-09-27       Impact factor: 5.719

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.